Centre to cap trade margins on cancer drugs, SC calls for broader price review
New Delhi, Oct 12 (IANS) The Centre on Monday informed the Supreme Court that it has decided to regulate trade margins on anti-cancer medicines by capping them at 30 per cent of the maximum retail price (MRP), while the apex court called…
Read More...
Read More...